Eli Lilly said Wednesday it is suing six companies selling versions of its experimental weight-loss drug retatrutide, calling it the beginning of a concerted effort to crack down on a vast illicit market. That market has boomed even though retatrutide is still being studied in clinical trials and hasn’t been approved by the Food and…
After surviving the deadliest antisemitic attack in U.S. history and presiding over multiple funerals for his slain congregants, Rabbi Jeffrey Myers struggled to pray. “There was this emptiness to it,” recalls Myers, of Tree of Life Congregation in Pittsburgh. He turned to the biblical Book of Psalms — its hymns, poetry and prayers covering “the entire…
Novo Nordisk sued competitor Eli Lilly on Tuesday, alleging the drugmaker engaged in false advertising by claiming its GLP-1 drugs are superior to Novo’s. The lawsuit accuses Eli Lilly of misleading consumers by using outdated clinical trial data to make Zepbound and Mounjaro appear more effective than Novo’s drugs, Wegovy and Ozempic, for weight loss…
